Skip to main content

Table 1 Correlation between HXOD-AS1 expression and clinical characteristics of bladder cancer patients

From: Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer

Parameters

Group

Total

HOXD-AS1 expression

P value

   

High(n = 30)

Low(n = 20)

 

Age(years)

<60

31

17

14

0.768

 

>60

19

12

7

 

Gender

Male

36

19

17

0.537

 

Female

14

9

5

 

Tumor size (cm)

<3 cm

18

6

12

0.006

 

≥3 cm

32

24

8

 

Histological grade

Low

22

9

13

0.044

 

Hight

28

20

8

 

TNM stage

I

29

9

20

0.009

 

II/III/IV

21

15

6

 

Lymphatic metastasis

N0

44

29

15

0.650

 

N1 or above

6

5

1

 
  1. P < 0.05 was considered significant. (Chi-square test was performed)